结合诱导多能干细胞 (iPSC) 技术与基于化学抗原受体 (CAR) 的免疫疗法:最近的进展,挑战和未来前景
Mehdi Alidadi1, Haniyeh Barzgar2, Mohammad Zaman3
1Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Frontiers in cell and developmental biology
|December 3, 2024
概括
诱导多能干细胞 (iPSCs) 为现成的仿真抗原受体 (CAR) -T细胞疗法提供了一个有前途的解决方案. 制造iPSC衍生的CAR-T细胞解决了当前治疗方法的局限性和临床翻译挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法是一种重要的抗癌治疗方法,但个性化制造存在挑战.
- 从全基源开发一个现成的CAR-T产品对于更快,更实惠,更标准化的患者治疗至关重要.
研究的目的:
- 审查诱导多能干细胞 (iPSC) 衍生的CAR-T (iCAR-T) 细胞的制造.
- 讨论iPSC衍生的CAR-T细胞的临床转化,挑战和替代方案.
主要方法:
- 关于iPSC衍生的CAR-T细胞制造和临床试验的当前文献的综述.
- 分析各种iPSC衍生的CAR工程细胞 (例如iCAR-NK,iCAR-巨细胞) 的优缺点.
主要成果:
- iPSCs为CAR-T细胞生成提供了无限的,均的细胞源,克服了批对批的不一致性.
- 包括iCAR-NK,iCAR-巨细胞和iCAR-中性粒细胞在内的各种iPSC衍生的CAR工程细胞正在评估临床使用.
结论:
- 从iPSC衍生的CAR-T细胞代表了开发现成采用细胞疗法的领先策略.
- 需要进一步的研究和开发,以克服基于iPSC的CAR工程细胞疗法的临床转化方面的挑战.
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


